Phospho-ΔNp63α-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure

FEBS Letters

Volumn 589, Issue 12, 2015, Pages 1352-1358

  Ratovitski, Edward A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Chemoresistance; Cisplatin; microRNA; Necroptosis; Tumor protein p63

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYLD PROTEIN, HUMAN; MICRORNA; MIRN101 MICRORNA, HUMAN; MLKL PROTEIN, HUMAN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECOMBINANT PROTEIN; RIPK1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

AGONISTS; ANTAGONISTS AND INHIBITORS; CARCINOMA, SQUAMOUS CELL; CELL DEATH; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; DRUG RESISTANCE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; NECROSIS; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL DEATH; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE SILENCING; GENES, REPORTER; HUMANS; MICRORNAS; NECROSIS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84937763878     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.04.020     Document Type: Article

References (38)

1. S. Elmore Apoptosis. Review of the programmed cell death Toxicol. Pathol. 35 2007 495 514
2. S. Fulda The mechanism of necroptosis in normal and cancer cells Cancer Biol. Ther. 14 2013 999 1004
3. S. Fulda Therapeutic exploitation of necroptosis for cancer therapy Semin. Cell Dev. Biol. 35 2014 51 56
4. J. Reyjal, K. Cormier, and S. Turcotte Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies Adv. Exp. Med. Biol. 772 2014 167 188
5. F. Radogna, M. Dicato, and M. Diederich Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target Biochem. Pharmacol. 94 2015 1 11
6. T. Vanden Berghe, A. Linkermann, S. Jouan-Lanhouet, H. Walczak, and P. Vandenabeele Regulated necrosis: the expanding network of non-apoptotic cell death pathways Nat. Rev. Mol. Cell Biol. 15 2014 135 147
7. L.S. Dickens, I.R. Powley, M.A. Hughes, and M. MacFarlane The 'complexities' of life and death: death receptor signalling platforms Exp. Cell Res. 318 2012 1269 1277
8. P. Borst, S. Rottenberg, and J. Jonkers How do real tumors become resistant to cisplatin? Cell Cycle 7 2008 1353 1359
9. X. Sui, L. Jin, X. Huang, S. Geng, C. He, and X. Hu P53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment Autophagy 7 2011 565 571
10. J.A. Freeman, and J.M. Espinosa The impact of post-transcriptional regulation in the p53 network Brief Funct. Genomics 12 2013 46 57
11. B. Trink, M. Osada, E. Ratovitski, and D. Sidransky P63 transcriptional regulation of epithelial integrity and cancer Cell Cycle 6 2007 240 245
12. E.A. Ratovitski Tumor protein p63/microRNA network in epithelial cancer cells Curr. Genomics 14 2013 441 452
13. O. Gressner, T. Schilling, K. Lorenz, E. Schulze-Schleithoff, A. Koch, H. Schulze-Bergkamen, A.M. Lena, E. Candi, A. Terrinoni, M.V. Catani, M. Oren, G. Melino, P.H. Krammer, W. Stremmel, and M. Müller TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria EMBO J. 24 2005 2458 2471
14. S.J. Seitz, E.S. Schleithoff, A. Koch, A. Schuster, A. Teufel, F. Staib, W. Stremmel, G. Melino, P.H. Krammer, T. Schilling, and M. Müller Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway Int. J. Cancer 126 2010 2049 2066
15. Y. Huang, T. Sen, J. Nagpal, S. Upadhyay, B. Trink, E. Ratovitski, and D. Sidransky ATM kinase is a master switch for the ΔNp63α phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage Cell Cycle 7 2008 2846 2855
16. Y. Huang, A. Chuang, H. Hao, C. Talbot, T. Sen, B. Trink, D. Sidransky, and E. Ratovitski Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells Cell Death Differ. 18 2011 1220 1230
17. Y. Huang, R. Guerrero-Preston, and E.A. Ratovitski Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation Cell Cycle 11 2012 1247 1259
18. E.A. Ratovitski Phospho-ΔNp63α-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: at the crossroads of cell life and death FEBS Lett. 587 2013 2536 2541
19. Y. Huang, and E.A. Ratovitski Phospho-ΔNp63α/Rpn13-dependent regulation of LKB1 degradation modulates autophagy in cancer cells Aging (Albany NY) 2 2010 959 968
20. E.A. Ratovitski Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas Cell Cycle 13 2014 749 761
21. E.A. Ratovitski, M.R. Alam, R.A. Quick, A. McMillan, C. Bao, C. Kozlovsky, T.A. Hand, R.C. Johnson, R.E. Mains, B.A. Eipper, and C.J. Lowenstein Kalirin inhibition of inducible nitric-oxide synthase J. Biol. Chem. 274 1999 993 999
22. S. Jouan-Lanhouet, M.I. Arshad, C. Piquet-Pellorce, C. Martin-Chouly, G. Le Moigne-Muller, F. Van Herreweghe, N. Takahashi, O. Sergent, D. Lagadic-Gossmann, P. Vandenabeele, M. Samson, and M.T. Dimanche-Boitrel TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation Cell Death Differ. 19 2012 2003 2014
23. J.H. Madenspacher, K.M. Azzam, K.M. Gowdy, K.C. Malcolm, J.A. Nick, D. Dixon, J.J. Aloor, D.W. Draper, J.J. Guardiola, M. Shatz, D. Menendez, J. Lowe, J. Lu, P. Bushel, L. Li, B.A. Merrick, M.A. Resnick, and M.B. Fessler P53 integrates host defense and cell fate during bacterial pneumonia J. Exp. Med. 210 2013 891 904
24. K. Moriwaki, J. Bertin, P.J. Gough, G.M. Orlowski, and F.K. Chan Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death Cell Death Dis. 6 2015 e1636
25. M. Dannappel, K. Vlantis, S. Kumari, A. Polykratis, C. Kim, L. Wachsmuth, C. Eftychi, J. Lin, T. Corona, N. Hermance, M. Zelic, P. Kirsch, M. Basic, A. Bleich, M. Kelliher, and M. Pasparakis RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis Nature 513 2014 90 94
26. K. Moriwaki, and F.K. Chan RIP3: a molecular switch for necrosis and inflammation Genes Dev. 27 2013 1640 1649
27. R.J. Thapa, S.H. Basagoudanavar, S. Nogusa, K. Irrinki, K. Mallilankaraman, M.J. Slifker, A.A. Beg, M. Madesh, and S. Balachandran NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis Mol. Cell. Biol. 31 2011 2934 2946
28. G. Imre, S. Larisch, and K. Rajalingam Ripoptosome: a novel IAP-regulated cell death-signalling platform J. Mol. Cell Biol. 3 2011 324 326
29. M. Feoktistova, P. Geserick, D. Panayotova-Dimitrova, and M. Leverkus Pick your poison: the Ripoptosome, a cell death platform regulating apoptosis and necroptosis Cell Cycle 11 2012 460 467
30. T. Bohgaki, J. Mozo, L. Salmena, E. Matysiak-Zablocki, M. Bohgaki, O. Sanchez, A. Strasser, A. Hakem, and R. Hakem Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim-/- mice J. Cell Biol. 195 2011 277 291
31. L. Galluzzi, O. Kepp, and G. Kroemer MLKL regulates necrotic plasma membrane permeabilization Cell Res. 24 2014 139 140
32. Z. Cai, S. Jitkaew, J. Zhao, H.C. Chiang, S. Choksi, J. Liu, Y. Ward, L.G. Wu, and Z.G. Liu Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis Nat. Cell Biol. 16 2014 55 65
33. X. Yu, Q. Deng, W. Li, L. Xiao, X. Luo, X. Liu, L. Yang, S. Peng, Z. Ding, T. Feng, J. Zhou, J. Fan, A.M. Bode, Z. Dong, J. Liu, and Y. Cao Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production Oncotarget 6 2015 1995 2008
34. Z. Fu, B. Deng, Y. Liao, L. Shan, F. Yin, Z. Wang, H. Zeng, D. Zuo, Y. Hua, and Z. Cai The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis BMC Cancer 13 2013 580
35. Z.A. Dunai, G. Imre, G. Barna, T. Korcsmaros, I. Petak, P.I. Bauer, and R. Mihalik Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells PLoS One 7 2012 e41945
36. K.E. McCabe, K. Bacos, D. Lu, J.R. Delaney, J. Axelrod, M.D. Potter, M. Vamos, V. Wong, N.D. Cosford, R. Xiang, and D.G. Stupack Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma Cell Death Dis. 5 2014 e1496
37. F. Basit, S. Cristofanon, and S. Fulda Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes Cell Death Differ. 20 2013 1161 1173
38. J. Hammerová, S. Uldrijan, E. Táborská, A.H. Vaculová, and I. Slaninová Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine Biol. Chem. 393 2012 647 658